Continuous monitoring of ascorbate transport through neuroblastoma cells with a ruthenium oxide hexacyanoferrate modified microelectrode

The Analyst ◽  
2008 ◽  
Vol 133 (11) ◽  
pp. 1605 ◽  
Author(s):  
Thiago R. L. C. Paixão ◽  
Lívea F. Barbosa ◽  
Maria T. Carrì ◽  
Marisa H. G. Medeiros ◽  
Mauro Bertotti
2006 ◽  
Vol 31 (6) ◽  
pp. 785-794 ◽  
Author(s):  
James M. May ◽  
Liying Li ◽  
Kendra Hayslett ◽  
Zhi-chao Qu

2009 ◽  
Vol 47 (01) ◽  
Author(s):  
N Billecke ◽  
S Tröller ◽  
N Raschzok ◽  
MH Morgül ◽  
NN Kammer ◽  
...  

2010 ◽  
Vol 222 (03) ◽  
Author(s):  
S Taschner-Mandl ◽  
A Kowalska ◽  
H Binder ◽  
D Rieder ◽  
Z Trajanoski ◽  
...  

2013 ◽  
Vol 225 (03) ◽  
Author(s):  
F Sherkheli ◽  
S Ackermann ◽  
F Roels ◽  
H Kocak ◽  
R Volland ◽  
...  

1990 ◽  
Vol 29 (03) ◽  
pp. 120-124
Author(s):  
R. P. Baum ◽  
E. Rohrbach ◽  
G. Hör ◽  
B. Kornhuber ◽  
E. Busse

The effect of triiodothyronine (T3) on the differentiation of cultured neuroblastoma (NB) cells was studied after 9 days of treatment with a dose of 10-4 M/106 cells per day. Using phase contrast microscopy, 30-50% of NB cells showed formation of neurites as a morphological sign of cellular differentiation. The initial rise of the mitosis rate was followed by a plateau. Changes in cyclic nucleotide content, in the triphosphates and in the activity of the enzyme ornithine decarboxylase (ODC) were assessed in 2 human and 2 murine cell lines to serve as biochemical parameters of the cell differentiation induced by T3. Whereas the cAMP level increased significantly (3 to 7 fold compared with its initial value), the cGMP value dropped to 30 to 50% of that of the control group. ATP and GTP increased about 200%, the ODC showed a decrease of about 50%. The present studies show a biphasic effect of T3 on neuroblastoma cells: the initial rise of mitotic activity is followed by increased cell differentiation starting from day 4 of the treatment.


Metrologiya ◽  
2020 ◽  
pp. 25-42
Author(s):  
Dmitrii V. Khablov

This paper describes a promising method for non-contact vibration diagnostics based on the use of Doppler microwave sensors. In this case, active irradiation of the object with electromagnetic waves and the allocation of phase changes using two-channel quadrature processing of the received reflected signal are used. The modes of further fine analysis of the resulting signal using spectral or wavelet transformations depending on the nature of the active vibration are considered. The advantages of this non-contact and remote vibration analysis method for the study of complex dynamic objects are described. The convenience of the method for machine learning and use in intelligent systems of non-destructive continuous monitoring of the state of these objects by vibration is noted.


2020 ◽  
Vol 27 (12) ◽  
pp. 699-710
Author(s):  
Irasema Mendieta ◽  
Gabriel Rodríguez-Gómez ◽  
Bertha Rueda-Zarazúa ◽  
Julia Rodríguez-Castelán ◽  
Winniberg Álvarez-León ◽  
...  

Neuroblastoma (NB) is the most common solid childhood tumor, and all-trans retinoic acid (ATRA) is used as a treatment to decrease minimal residual disease. Molecular iodine (I2) induces differentiation and/or apoptosis in several neoplastic cells through activation of PPARγ nuclear receptors. Here, we analyzed whether the coadministration of I2 and ATRA increases the efficacy of NB treatment. ATRA-sensitive (SH-SY5Y), partially-sensitive (SK-N-BE(2)), and non-sensitive (SK-N-AS) NB cells were used to analyze the effect of I2 and ATRA in vitro and in xenografts (Foxn1 nu/nu mice), exploring actions on cellular viability, differentiation, and molecular responses. In the SH-SY5Y cells, 200 μM I2 caused a 100-fold (0.01 µM) reduction in the antiproliferative dose of ATRA and promoted neurite extension and neural marker expression (tyrosine hydroxylase (TH) and tyrosine kinase receptor alpha (Trk-A)). In SK-N-AS, the I2 supplement sensitized these cells to 0.1 μM ATRA, increasing the ATRA-receptor (RARα) and PPARγ expression, and decreasing the Survivin expression. The I2 supplement increased the mitochondrial membrane potential in SK-N-AS suggesting the participation of mitochondrial-mediated mechanisms involved in the sensibilization to ATRA. In vivo, oral I2 supplementation (0.025%) synergized the antitumor effect of ATRA (1.5 mg/kg BW) and prevented side effects (body weight loss and diarrhea episodes). The immunohistochemical analysis showed that I2 supplementation decreased the intratumoral vasculature (CD34). We suggest that the I2 + ATRA combination should be studied in preclinical and clinical trials to evaluate its potential adjuvant effect in addition to conventional treatments.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 917-P
Author(s):  
RYO KUMAGAI ◽  
AIKO MURAMATSU ◽  
MASANAO FUJII ◽  
YUKINO KATAKURA ◽  
KEIKO FUJIE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document